Skip to main content
. 2013 Jul 24;2013:574310. doi: 10.1155/2013/574310

Figure 2.

Figure 2

Comparison of HFA227 formulations in terms of drug deposited on each stage of Next Generation Impactor, maintaining constant concentration of ethanol (data represent mean ± SD, n = 3). MOC: microorifice collector. *P < 0.05 (ANOVA/Tukey's) 5.45% w/w Pluronic L81 versus 0 and 1.22% w/w Pluronic L81, **P < 0.05 (ANOVA/Tukey's) comparing all formulations, $ P < 0.05 (ANOVA/Tukey's) 1% w/w Pluronic L81 versus 0 and 5% w/w Pluronic L81, and # P < 0.05 (ANOVA/Tukey's) 0% w/w Pluronic L81 versus 1.22 and 5% w/w Pluronic L81.